KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Debt Ratio (2016 - 2025)

Ionis Pharmaceuticals has reported Debt Ratio over the past 17 years, most recently at 0.13 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.13 for Q4 2025, up 655.25% from a year ago — trailing twelve months through Dec 2025 was 0.13 (up 655.25% YoY), and the annual figure for FY2025 was 0.13, up 655.25%.
  • Debt Ratio for Q4 2025 was 0.13 at Ionis Pharmaceuticals, down from 0.21 in the prior quarter.
  • Over the last five years, Debt Ratio for IONS hit a ceiling of 0.21 in Q2 2025 and a floor of 0.0 in Q1 2023.
  • Median Debt Ratio over the past 5 years was 0.02 (2024), compared with a mean of 0.05.
  • Biggest five-year swings in Debt Ratio: tumbled 78.08% in 2022 and later surged 1341.29% in 2025.
  • Ionis Pharmaceuticals' Debt Ratio stood at 0.02 in 2021, then tumbled by 73.97% to 0.01 in 2022, then soared by 357.15% to 0.03 in 2023, then crashed by 40.01% to 0.02 in 2024, then surged by 655.25% to 0.13 in 2025.
  • The last three reported values for Debt Ratio were 0.13 (Q4 2025), 0.21 (Q3 2025), and 0.21 (Q2 2025) per Business Quant data.